Zywie, Inc.

Zywie, Inc. is a remote cardiac monitoring company delivering next-generation mobile cardiac telemetry (MCT) solutions for arrhythmia detection and continuous heart rhythm monitoring. The company manufactures the ZywieNano™ MCT Patch, a miniaturized biosensor worn as a patch for up to 30 days of continuous ECG monitoring. Core offerings include the patch device, a proprietary mobile application for patient engagement, AI-driven rhythm analysis (ZywieAI®), near real-time data transmission to clinicians, and 24/7 patient support services. The platform targets cardiology practices, primary care providers, and patients with suspected or known cardiac arrhythmias, atrial fibrillation, and syncope. Zywie's technology enables extended monitoring periods (15–30 days) versus traditional Holter monitors (24–48 hours), with integrated event logging, symptom tracking, and clinical decision support. The system provides advanced rhythm analysis including detection of ventricular tachycardia, atrial fibrillation, pauses, and bradycardia. The company serves 500,000+ patients and has processed over 1 trillion heartbeats. Regulatory status, specific FDA clearance details, and ISO certifications are not explicitly stated on the website. Zywie operates corporate headquarters in Johns Creek, Georgia and a clinical headquarters in Walnut Creek, California.